Bing Center for Waldenstrom's Macroglobulinemia - Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab

You are here: Home

Publications

Pub-2011

Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab

Can't see this document? Click Here

Legal | Privacy